Influence of vitamin D supplementation by sunlight or oral D3 on exercise performance by Carswell, Alexander T. et al.
  
 
P
R
IF
Y
S
G
O
L
 B
A
N
G
O
R
 /
 B
A
N
G
O
R
 U
N
IV
E
R
S
IT
Y
 
 
Influence of vitamin D supplementation by sunlight or oral D3 on exercise
performance
Carswell, Alexander T.; Oliver, Samuel J.; Wentz, Laurel M.; Kashi, Daniel S.;
Roberts, Ross; Tang, Jonathan C.; Izard, Rachel M.; Jackson, Sarah ; Allan,
Donald ; Rhodes, Lesley E.; Fraser, William D.; Greeves, Julie P.; Walsh, Neil P.
Medicine and Science in Sports and Exercise
DOI:
10.1249/MSS.0000000000001721
Published: 01/12/2018
Peer reviewed version
Cyswllt i'r cyhoeddiad / Link to publication
Dyfyniad o'r fersiwn a gyhoeddwyd / Citation for published version (APA):
Carswell, A. T., Oliver, S. J., Wentz, L. M., Kashi, D. S., Roberts, R., Tang, J. C., ... Walsh, N. P.
(2018). Influence of vitamin D supplementation by sunlight or oral D3 on exercise performance.
Medicine and Science in Sports and Exercise, 50(12), 2555-2564.
https://doi.org/10.1249/MSS.0000000000001721
Hawliau Cyffredinol / General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or
other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal
requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private
study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to
the work immediately and investigate your claim.
 22. Jun. 2020
D
ow
nloaded
from
https://journals.lw
w
.com
/acsm
-m
sse
by
B
hD
M
f5eP
H
K
av1zE
oum
1tQ
fN
4a+kJLhE
ZgbsIH
o4X
M
i0hC
yw
C
X
1A
W
nY
Q
p/IlQ
rH
D
3vZhfaA
jm
m
eO
R
g0sG
dS
S
/Z5m
U
V
Y
w
2B
D
Q
pS
W
0nQ
lV
TX
yo=
on
08/17/2018
Downloadedfromhttps://journals.lww.com/acsm-mssebyBhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3vZhfaAjmmeORg0sGdSS/Z5mUVYw2BDQpSW0nQlVTXyo=on08/17/2018
 
. . . Published ahead of Print 
 
 
 
Medicine & Science in Sports & Exercise® Published ahead of Print contains articles in unedited 
manuscript form that have been peer reviewed and accepted for publication. This manuscript will undergo 
copyediting, page composition, and review of the resulting proof before it is published in its final form. 
Please note that during the production process errors may be discovered that could affect the content. 
 
Copyright © 2018 the Author(s). Published by Wolters Kluwer Health on behalf of the 
American College of Sports Medicine  
Influence of Vitamin D Supplementation by Sunlight or 
Oral D3 on Exercise Performance 
 
 
Alexander T. Carswell
1
, Samuel J. Oliver
1
, Laurel M. Wentz
2
, Daniel S. Kashi
1
, Ross Roberts
1
, 
Jonathan C. Y. Tang
3
, Rachel M. Izard
4
, Sarah Jackson
5
, Donald Allan
6
, Lesley E. Rhodes
7
, 
William D. Fraser
3
, Julie P. Greeves
5
, and Neil P. Walsh
1 
 
1
College of Health and Behavioural Sciences, Bangor University, Bangor, Gwynedd, United 
Kingdom; 
2
Department of Nutrition and Health Care Management, Appalachian State 
University, Boone, NC; 
3
Faculty of Medicine and Health Science, Norwich Medical School, 
University of East Anglia, Norwich, Norfolk, United Kingdom; 
4
Occupational Medicine, 
Headquarters Army Recruiting and Training Division, Upavon, Wiltshire, United Kingdom; 
5
Army Personnel and Research Capability, Army HQ, Andover, Hampshire, United 
Kingdom; 
6
Medical Physics Department, Salford Royal NHS Foundation Trust, and 
University of Manchester, Manchester Academic Health Science Centre, Manchester, United 
Kingdom; 
7
Faculty of Biology, Medicine and Health, University of Manchester, and 
Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health 
Science Centre, Manchester, United Kingdom 
 
 
 
Accepted for Publication: 3 July 2018 AC
EP
TE
D
Influence of Vitamin D Supplementation by Sunlight or Oral D3 on Exercise 
Performance 
 
Alexander T. Carswell
1
, Samuel J. Oliver
1
, Laurel M. Wentz
2
, Daniel S. Kashi
1
, Ross Roberts
1
, 
Jonathan C. Y. Tang
3
, Rachel M. Izard
4
, Sarah Jackson
5
, Donald Allan
6
, Lesley E. Rhodes
7
, 
William D. Fraser
3
, Julie P. Greeves
5
, and Neil P. Walsh
1 
 
1
College of Health and Behavioural Sciences, Bangor University, Bangor, Gwynedd, United 
Kingdom; 
2
Department of Nutrition and Health Care Management, Appalachian State 
University, Boone, NC; 
3
Faculty of Medicine and Health Science, Norwich Medical School, 
University of East Anglia, Norwich, Norfolk, United Kingdom; 
4
Occupational Medicine, 
Headquarters Army Recruiting and Training Division, Upavon, Wiltshire, United Kingdom; 
5
Army Personnel and Research Capability, Army HQ, Andover, Hampshire, United Kingdom; 
6
Medical Physics Department, Salford Royal NHS Foundation Trust, and University of 
Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom; 
7
Faculty of Biology, Medicine and Health, University of Manchester, and Dermatology Centre, 
Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, 
Manchester, United Kingdom 
 
Corresponding Author: 
Prof. Neil P. Walsh FACSM 
College of Health and Behavioural Sciences 
Bangor University 
AC
CE
PT
ED
Medicine & Science in Sports & Exercise, Publish Ahead of Print 
DOI: 10.1249/MSS.0000000000001721
Bangor 
LL57 2PZ 
UK 
Email:  n.walsh@bangor.ac.uk 
Telephone: + 44 1248 383480 
 
This work was funded by the Ministry of Defence (Army), UK. Conflict of interest: None 
declared. The results of Study 1 and Study 2 are presented clearly, honestly, and without 
fabrication, falsification, or inappropriate data manipulation; and, they do not constitute 
endorsement by ACSM. 
 
Copyright © 2018 the Author(s). Published by Wolters Kluwer Health on behalf of the American 
College of Sports Medicine. This is an open-access article distributed under the terms of the 
Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), 
where it is permissible to download and share the work provided it is properly cited. The work 
cannot be changed in any way or used commercially without permission from the journal. 
  
AC
CE
PT
ED
ABSTRACT  
Purpose: To determine the relationship between vitamin D status and exercise performance in a 
large, prospective cohort study of young men and women across seasons (Study-1). Then, in a 
randomized, placebo-controlled trial, to investigate the effects on exercise performance of 
achieving vitamin D sufficiency (serum 25(OH)D ≥ 50 nmol·L-1) by a unique comparison of 
safe, simulated-sunlight and oral vitamin D3 supplementation in wintertime (Study-2). Methods: 
In Study-1, we determined 25(OH)D relationship with exercise performance in 967 military 
recruits. In Study-2, 137 men received either placebo, simulated-sunlight (1.3x standard 
erythemal dose in T-shirt and shorts, three-times-per-week for 4-weeks and then once-per-week 
for 8-weeks) or oral vitamin D3 (1,000 IU∙day
-1
 for 4-weeks and then 400 IU∙day-1 for 8-weeks). 
We measured serum 25(OH)D by LC-MS/MS and endurance, strength and power by 1.5-mile 
run, maximum-dynamic-lift and vertical jump, respectively. Results: In Study-1, only 9% of 
men and 36% of women were vitamin D sufficient during wintertime. After controlling for body 
composition, smoking and season, 25(OH)D was positively associated with endurance 
performance (P ≤ 0.01, ∆R2 = 0.03–0.06, small f2 effect sizes): 1.5-mile run time was ~half-a-
second faster for every 1 nmol·L
-1 
increase in 25(OH)D. No significant effects on strength or 
power emerged (P > 0.05). In Study-2, safe simulated-sunlight and oral vitamin D3 
supplementation were similarly effective in achieving vitamin D sufficiency in almost all (97%); 
however, this did not improve exercise performance (P > 0.05). Conclusion: Vitamin D status 
was associated with endurance performance but not strength or power in a prospective cohort 
study. Achieving vitamin D sufficiency via safe, simulated summer sunlight or oral vitamin D3 
supplementation did not improve exercise performance in a randomized-controlled trial. 
Key words: cholecalciferol; 25-hydroxyvitamin D; UVB; endurance; strength; power.  
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INTRODUCTION 
Vitamin D can be obtained from dietary sources but is primarily synthesized by skin exposure to 
sunlight ultraviolet B (UVB) radiation. Those who live at latitudes > 35° or live indoors for the 
majority of sunlight hours and cover-up from the sun are at higher risk for vitamin D 
insufficiency (serum 25-hydroxyvitamin D (25(OH)D) < 50 nmol·L
-1
 (1, 2)). Avoiding low 
serum 25(OH)D is essential for musculoskeletal health with current Institute of Medicine (IOM) 
and European Food Safety Authority (EFSA) recommendations to maintain serum 25(OH)D 
concentration ≥ 50 nmol·L-1 (3, 4).  
Vitamin D stimulates skeletal muscle protein synthesis via vitamin D receptor (VDR) mediated 
signalling (5), and may improve cardiac and endothelial function (6, 7); as such, avoiding low 
serum 25(OH)D and achieving vitamin D sufficiency may be important for both strength and 
endurance type exercise (1, 8). Positive associations between vitamin D status and physical 
performance have been reported in studies with elderly participants (9); for example, correcting 
vitamin D deficiency (serum 25(OH)D < 30 nmol·L
-1
) has been shown to increase strength in the 
elderly (10). Whether vitamin D has measurable and meaningful effects on exercise performance 
in young otherwise healthy adults is a matter of continued debate (11). Cross-sectional studies 
investigating the influence of vitamin D status on exercise performance in young healthy adults 
often present conflicting findings (12); likely contributing factors include small samples sizes 
and a lack of control over variables that may influence exercise performance (i.e. age, sex, body 
composition, smoking, physical activity and season) (8, 13, 14). Interpreting the findings from 
vitamin D supplementation studies is also challenging (11). The participant populations in some 
supplementation studies were vitamin D sufficient at baseline (15, 16),
 
and studies have used 
greater than currently recommended oral and ultraviolet radiation (UVR) doses; raising the risk 
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of vitamin D toxicity (15, 17, 18) (tolerable upper intake 4,000 IU∙day-1) (3, 4) and sunburn, 
which is a risk factor for skin cancer (19). Claims have been made of benefits to exercise 
performance in early UVR studies using sun lamps (8), including purported benefits of UVR for 
cardiovascular fitness and local muscular endurance (20). Although intriguing, these claims 
should be interpreted with due caution as the studies involved were not placebo-controlled and 
they made no assessment of serum 25(OH)D (20). As such, randomized, placebo-controlled 
trials investigating the influence of recommended oral vitamin D supplementation and safe 
simulated sunlight exposure on vitamin D status and exercise performance are required. 
Here we present results from a prospective cohort study conducted during all seasons (Study 1) 
and a randomized, placebo-controlled supplementation study that commenced in the UK winter, 
when vitamin D status was at its nadir (Study 2). In Study 1, we examined the relationship 
between serum 25(OH)D and endurance, strength and power exercise performance in 967 young, 
healthy men and women, after adjusting for variables considered to influence exercise 
performance (e.g. body composition, smoking and season). In Study 2, we determined the effect 
of 12-weeks vitamin D supplementation, by either simulated sunlight in accordance with 
recommendations on safe, casual sunlight exposure (21), or oral vitamin D3, on serum 25(OH)D 
and exercise performance. We hypothesized that wintertime vitamin D supplementation 
achieving vitamin D sufficiency (serum 25(OH)D ≥ 50 nmol·L-1) would improve exercise 
performance. 
METHODS 
Studies received ethics approval from the UK Ministry of Defence Research Ethics Committee 
and were conducted in accordance with the Declaration of Helsinki (2013). British Army recruit 
volunteers participated in Study 1 and Study 2 after providing fully informed written consent and 
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passing a physician-screened medical assessment. Men (Study 1 and Study 2) were located at 
Infantry Training Centre Catterick, UK (latitude 54°N) and women (Study 1) were located at 
Army Training Centre Pirbright, UK (latitude 51°N). All volunteers were studied during Basic 
Military Training that follows a generic syllabus of basic military skills including physical 
training, weapon handling, map reading and field craft. The progressive, structured, physical 
training program included: endurance training, typically involving running in groups, with and 
without load carriage; circuit training, consisting of high-repetition, low force exercises using all 
major muscle groups; agility based gymnasium work using benches and ropes; and assault 
course practice. Marching with various loads while on military exercise, and military drill were 
also undertaken. 
 
Study one  
Participants and study design. Nine-hundred and sixty-seven men and women recruits (age 22 
± 3 years; 95% white ethnicity; n = 621 men: body mass 75.0 ± 10.0 kg; height 1.78 ± 0.06 m; 
body mass index (BMI) 23.8 ± 2.8 kg∙m-2; body fat 19.8 ± 5.3%; current smokers 45%; n = 346 
women: body mass 63.9 ± 7.9 kg; height 1.65 ± 0.06 m; BMI 23.4 ± 2.4 kg∙m-2; body fat 30.2 ± 
4.9%; current smokers 25%) participated in this prospective cohort study between January 2014 
and September 2015.  
Experimental procedures. We collected baseline measurements from each participant during 
week 1 of training; including a venous blood sample for the determination of serum 25(OH)D; 
body composition by dual-energy x-ray absorptiometry (DXA, Lunar iDXA, GE Healthcare, 
Buckinghamshire, UK); ethnicity and smoking history by questionnaire; and exercise 
performance. During the DXA participants were instructed to lie motionless in the supine 
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position for the duration of the scan, with straps fitted around their lower limbs to minimize 
movement. Men wore only underwear, and women wore light clothing. The DXA scanner was 
calibrated each morning before use. To assess endurance exercise performance, the time to 
complete a best effort 1.5-mile run on an outdoor course was recorded to the nearest second. The 
1.5-mile run is used widely among military personnel, with performance indicative of an 
individual’s maximal aerobic capacity (22). Participants were highly motivated because their 
best effort was required for progression in their military careers. We determined maximum 
strength as the maximal weight lifted on a machine that simulates a power clean weightlifting 
movement, as described previously (23). Explosive power was assessed by counter-movement 
jump using a jump mat (Takei Scientific Instruments, Tokyo, Japan), as described (23), along 
with the following validated equation: explosive power (W) = (51.9 x maximal vertical jump 
height (cm)) + (48.9 x body mass (kg)) – 2007 (24). Participants were instructed to jump as high 
as possible three times, with their hands placed on their hips to prevent upper limb assistance. 
Where an increase in jump height occurred across jumps 1–3, indicative of a learning effect, a 
fourth jump was made. Maximal vertical jump height was recorded as the highest score 
achieved. Test-retest reliability of r ≥ 0.90 has been reported for these performance tests (23). 
After 12-weeks of training, a cohort of 331 participants (170 men and 161 women) repeated 
baseline measurements; these participants were randomly selected throughout the year to provide 
a full seasonal spread for follow-up measurements. In addition, medical records were accessed to 
calculate the number of incomplete training days due to illness or injury for each participant.  
Study two  
Participants and study design. Men were eligible to participate in this double-blind, 
randomized, placebo-controlled trial if they had sun-reactive skin type I–IV (25); were not 
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currently consuming supplements containing vitamin D; and had not used a sun bed or travelled 
to a sunny climate in the 3-months before the study. The study took place in 2016 and 2017, with 
participants commencing in January or February when ambient UVB was negligible at UK 
latitudes. One-hundred and thirty-seven men completed the 12-week intervention with a 
compliance ≥ 80% (100% white ethnicity; age 22 ± 3 years; body mass 77.0 ± 11.5 kg; height 
1.77 ± 0.06 m; BMI 24.4 ± 2.8 kg∙m-2; body fat 21.5 ± 5.3%; current smokers 34%). There were 
no differences between treatment and control groups for demographics, anthropometrics and 
serum vitamin D metabolites at baseline. 
Experimental procedures. Participants were block randomized within their platoons to one of 
four, 12-week intervention groups: 1) solar simulated radiation (SSR); 2) solar simulated 
radiation placebo (SSR-P); 3) oral vitamin D3 (ORAL); or 4) oral placebo (ORAL-P). Block 
randomization (using randomizer.org) resulted in an equal distribution of intervention groups 
within each platoon, and therefore ensured any differences in training conditions between 
platoons did not influence the study outcomes. The intervention strategy for the SSR and ORAL 
groups was to restore and then maintain IOM and EFSA recommended vitamin D sufficiency 
(serum 25(OH)D ≥ 50 nmol·L-1). Participants completed a 4-week restoration phase, necessary 
because 25(OH)D was at its winter nadir, followed by an 8-week maintenance phase (Fig. 1). 
Before and after the restoration and maintenance phases, exercise performance was assessed 
using identical procedures to Study 1 and a venous blood sample was collected for the 
determination of serum vitamin D metabolites. Vitamin D from the diet was estimated in week 
12 using a food frequency questionnaire, and solar UVR exposure was measured in weeks 4 and 
11 using polysulphone badges (26). Dietary vitamin D intake was then calculated, excluding that 
which participants in the ORAL group received from their intervention. On completion of the 
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study, participants were asked to guess which intervention i.e. active or control they thought they 
had been receiving. 
Simulated sunlight. Simulated sunlight was provided in accordance with guidelines on safe 
sunlight exposure for vitamin D synthesis (21); described previously to achieve serum 25(OH)D 
≥ 50 nmol·L-1 in the majority of white skinned persons (19). Those assigned to the SSR 
intervention were exposed three-times-a-week during the restoration phase to an experimenter-
controlled constant UVR dose using a whole body irradiation cabinet (Hapro Jade, Kapelle, The 
Netherlands) fitted with Arimed B fluorescent tubes (Cosmedico, Stuttgart, Germany). The 
fluorescent tubes emitted a UVR spectrum similar to sunlight (λ: 290–400 nm; 95% UVA: 320–
400 nm, 5% UVB: 290–320 nm) that was characterized by a spectroradiometer (USB2000+, 
Ocean Optics BV, Duiven, The Netherlands) radiometrically calibrated with traceability to UK 
national standards. During each exposure, participants received a 1.3x standard erythemal dose 
(SED) whilst wearing shorts and T-shirt to expose ~40% skin surface area. This dose is 
equivalent to ~15 minutes, midday summer sun exposure six-times-per-week for a casually 
dressed individual in northern England (latitude 53.5°N) (19) and taking account of pre-vitamin 
D irradiance at different latitudes, can be related to exposure times at other world locations (27). 
For example, the equivalent exposure time in Philadelphia, Pennsylvania, USA (40°N) would be 
~12 minutes; and that for Oslo, Norway (60°N) would be ~18 minutes. During the maintenance 
phase, we exposed SSR participants to the same 1.3x SED dose only once-a-week: pilot 
investigations confirmed the required dose to maintain sufficiency (serum 25(OH)D ≥ 50 
nmol·L
-1
). A constant SSR dose was maintained during the study by monitoring irradiance using 
a spectroradiometer (USB2000+, Ocean Optics BV) and adjusting for any decrease in measured 
irradiance emitted by increasing exposure time, as described (19) (mean duration of SSR 
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exposures was 222 ± 23 s). We controlled the exposure time by using an electronic timer on the 
irradiation cabinet. For the SSR-P participants the number of intervention exposures each week 
and the exposure duration were the same as SSR except the irradiation cabinet fluorescent tubes 
were covered with transparent UVR blocking film (DermaGard UV film, SunGard, Woburn, 
Massachusetts, USA). Spectroradiometry confirmed the UVR blocking film was effective at 
preventing transmission of 99.9% of UVR.  
Oral vitamin D3. Participants receiving the ORAL intervention consumed a vitamin D3 capsule 
daily, containing a 1,000 IU dose during the restoration phase and a 400 IU dose during the 
maintenance phase (Pure Encapsulations, Sudbury, Massachusetts, USA). The restoration dose 
was based on previous predictive modelling to achieve serum 25(OH)D ≥ 50 nmol·L-1 (28), and 
pilot investigations that showed it achieved similar serum 25(OH)D concentrations to SSR; and 
was less than the tolerable upper intake recommended by the IOM and EFSA (3, 4). The ORAL 
maintenance dose was also in accordance with recommendations (3, 29). For 12-weeks, ORAL-P 
participants consumed an identical looking cellulose placebo capsule daily (Almac Group, 
County Armagh, UK). Independent analysis found the vitamin D3 content of the 1,000 and 400 
IU capsules to be 1,090 and 460 IU, respectively and confirmed the placebo did not contain 
vitamin D (NSF International Laboratories, Ann Arbor, Michigan, USA). 
Blood collection and analysis. Whole blood samples were collected by venepuncture from an 
antecubital vein into plain vacutainer tubes (Becton Dickinson, Oxford, UK) and left to clot for 1 
hour. Subsequently, samples were centrifuged at 1500g for 10 minutes at 4°C and the serum 
aliquoted into universal tubes before being immediately frozen at -80°C for later analysis. Total 
serum 25(OH)D was measured with high-pressure liquid chromatography tandem mass 
spectrometry; and serum 1,25-dihydroxyvitamin D (1,25(OH)2D; Study 2) using the DiaSorin 
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LIAISON XL 1,25(OH)2D chemiluminescent immunoassay (Stillwater, Minnesota, USA) 
method. Analyses were performed in a Vitamin D External Quality Assurance Scheme certified 
laboratory (Bioanalytical Facility, University of East Anglia, Norwich, UK). 
Statistical analysis. In Study 1, hierarchical multiple linear regression was used to determine the 
association between 25(OH)D and exercise performance at baseline and follow-up. For the 1.5-
mile run, fat mass, smoking and season were included as covariates (8, 13, 14). For maximum 
dynamic lift strength and explosive power, covariates were lean body mass, smoking, height and 
season (8). Follow-up regression models included baseline covariates with the addition of 
incomplete training days to control for injury and illness (30, 31). For these analyses, we 
estimated a minimum sample size of 155 using effect sizes from a previous study (32) and 
standard formula (n ≥ (8 / f2) + (number of predictors – 1)) (33). We completed final analyses on 
967 participants after removing 2 men with z-scores ≥ 99.9th percentile for baseline 25(OH)D 
and 1.5-mile run time. We calculated Cohen’s f2 effect size for 25(OH)D using standard formula 
(34). We also compared exercise performance between baseline serum 25(OH)D quartiles using 
one-way ANOVA, and calculated Cohen’s d effect size (34). To correct the positive skew of 
variables not normally distributed, we log or square root transformed fat mass, lean body mass 
and serum 25(OH)D, where necessary. As required, we corrected the negative skew of 1.5-mile 
run time using a cube transformation. We used paired-sample t-tests to compare exercise 
performance between baseline and follow-up. In Study 2, we used mixed model ANOVA to 
compare vitamin D metabolites and exercise performance between vitamin D supplementation 
(SSR and ORAL combined together) and placebo groups. A sample size estimation for this 
analysis indicated that 19 participants per group were required to produce an 80% chance of 
obtaining statistical significance at the 0.05 level, based on the effect size (f  = 0.175) and 
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correlation between repeated measures (r = 0.67) determined from Study 1 run time data 
(G*Power, version 3.1.9.2). In addition, we compared individual active interventions to their 
respective placebos (SSR vs. SSR-P; and ORAL vs. ORAL-P) by mixed model ANOVA. Where 
statistically significant interactions were found, simple main effects were explored with one-way 
repeated measures ANOVA and independent t-tests. Statistical analyses were performed using 
SPSS Statistics 22.0 (IBM, Armonk, New York, USA). Statistical significance was accepted at P 
< 0.05. 
 
RESULTS  
Study one   
Exercise performance. For participants who completed measures at baseline and follow-up, 1.5-
mile run time was faster at follow-up (men 627 ± 48 vs. 578 ± 31 s; women 699 ± 54 vs. 667 ± 
44 s; P < 0.001). Maximum dynamic lift strength decreased in men (71 ± 12 vs. 68 ± 11 kg; P < 
0.01) but did not change in women (43 ± 9 vs. 44 ± 9 kg; P > 0.05). From baseline to follow-up, 
explosive power decreased in men (3868 ± 619 vs. 3797 ± 573 W; P < 0.01) but increased in 
women (2766 ± 465 vs. 2840 ± 436 W; P < 0.01).  
Low vitamin D status during winter. Baseline winter serum 25(OH)D was lower than all other 
seasons in men and lower than summer and fall in women (P < 0.001; Fig. 2A). During winter, 
only 9% of men and 36% of women were vitamin D sufficient (baseline 25(OH)D ≥ 50 nmol·L-
1
; Fig. 2B).  
Vitamin D status predicts endurance exercise performance. Using hierarchical multiple 
linear regression, serum 25(OH)D predicted endurance exercise performance after controlling for 
fat mass, smoking, and season; baseline serum 25(OH)D accounted for 4% and 6% of the 
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variance in 1.5-mile run time in men and women, respectively (Table 1). Every 1 nmol·L
-1 
increase in 25(OH)D translated into 0.42 ± 0.16 s faster (± 95% CI) 1.5-mile run time in men and 
0.57 ± 0.25 s faster 1.5-mile run time in women. Although statistically significant, the small 
Cohen’s f2 effect sizes indicate the magnitude of additional variance explained in endurance 
performance by serum 25(OH)D is relatively small (Table 1). These relationships were not 
reliant on participants with high or low 25(OH)D concentrations because positive associations 
remained after removing men and women with 25(OH)D ≥ 75 or < 30 nmol·L-1 (P < 0.05). At 
follow-up, after 12-weeks of training, 25(OH)D was again positively associated with endurance 
exercise performance irrespective of whether the number of incomplete training days was 
included in the model; 25(OH)D explained 6% and 3% of the variance in 1.5-mile run time in 
men and women, respectively, after controlling for fat mass, smoking, season, and the number of 
incomplete training days (Table 1). Using a simple one-way ANOVA, i.e. without control for 
body composition, smoking and season, 1.5-mile run time was fastest among men with baseline 
serum 25(OH)D in the highest quartile (> 75 nmol·L
-1
, P < 0.05, Cohen’s d effect size = 0.4); a 
similar trend was observed in women (Fig. 2C, P < 0.1; Cohen’s d effect size = 0.4).  
Vitamin D status was not associated with strength or power exercise performance. Serum 
25(OH)D was not significantly associated with maximum dynamic lift strength, or explosive 
power in men or women after controlling for lean mass, smoking, height and season (P > 0.05). 
At follow-up, once again 25(OH)D was not associated with maximum dynamic lift strength, or 
explosive power in men or women (P > 0.05). Analyzing quartiles of baseline serum 25(OH)D 
using simple one-way ANOVA, there were no differences in maximum dynamic lift strength or 
explosive power (P > 0.05). 
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Study two  
During the 12-week intervention, daily sunlight exposure (0.22 ± 0.33 SED·day
-1
; P > 0.05) and 
daily dietary vitamin D intake were not different between groups (120 ± 88 IU·day
-1
, P > 0.05). 
Participants were sufficiently blinded to the intervention since only 35% correctly guessed their 
allocated group, 32% were incorrect, and 33% said they did not know whether they had received 
an active or placebo intervention. 
Safe simulated sunlight and oral vitamin D3 restored vitamin D sufficiency in almost all. At 
baseline, ~three-quarters (74%) of volunteers were vitamin D insufficient (serum 25(OH)D < 50 
nmol·L
-1
) and ~one-third (31%) were vitamin D deficient (serum 25(OH)D < 30 nmol·L
-1
). Both 
SSR and ORAL supplementation were successful strategies to achieve vitamin D sufficiency and 
maintain serum 25(OH)D concentrations so that at week 5 and 12 serum 25(OH)D 
concentrations in the SSR and ORAL groups were higher than their respective placebo groups (P 
< 0.001; Fig. 3). Indeed, by week 5 almost all SSR and ORAL participants were vitamin D 
sufficient (97%: serum 25(OH)D ≥ 50 nmol·L-1) and none were vitamin D deficient (serum 
25(OH)D < 30 nmol·L
-1
); additionally, more than half (59%) had achieved the proposed optimal 
serum 25(OH)D ≥ 75 nmol·L-1 (1, 2, 35). Serum 1,25(OH)2D increased from baseline in the SSR 
and ORAL groups (P < 0.05; Fig. 4), and was higher than placebo groups at week 5 (P < 0.05). 
There was no difference between groups at week 12 (P > 0.05) because serum 1,25(OH)2D 
increased from week 5 to 12 in the placebo groups (P < 0.01). 
Safe simulated sunlight and oral vitamin D3 did not affect exercise performance. Vitamin D 
supplementation that achieved vitamin D sufficiency in almost all participants did not affect 1.5-
mile run time, maximum dynamic lift strength or explosive power (Table 2, all interaction P 
values > 0.05). Furthermore, participants on SSR and ORAL that achieved the proposed optimal 
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vitamin D status (serum 25(OH)D ≥ 75 nmol·L-1) by week 5 did not improve their 1.5-mile run 
time more than those who received placebo and remained vitamin D insufficient (1.5-mile run 
time improvement by week 5: participants ≥ 75 nmol·L-1 -28 ± 32 s vs. participants on placebo 
and < 50 nmol·L
-1
 -24 ± 34 s, P > 0.05, Cohen’s d effect size = 0.1). Additionally, those who 
achieved proposed optimal vitamin D status by week 12 did not improve their 1.5-mile run time, 
maximum dynamic lift strength or explosive power more than those who remained vitamin D 
insufficient (P > 0.05). As expected, 1.5-mile run time improved during training; however, 
explosive power decreased during training (Table 2, main effect of time; P < 0.01). 
 
DISCUSSION 
Primary findings and strengths 
In Study 1, in 967 young, healthy military recruits, we showed there was no influence of vitamin 
D status on muscular strength and power; however, a novel finding was that serum 25(OH)D was 
positively associated with endurance running performance in both men and women (Table 1). 
The findings of Study 1 can be considered robust as they were observed in men and women; 
after controlling for body composition, smoking, and season; and after removing those with low 
or high vitamin D status (serum 25(OH)D < 30 or ≥ 75 nmol·L-1). Study 1 is the first to control 
for body composition in regression models investigating the relationship between vitamin D 
status and endurance running performance. Controlling for body composition is important 
because excess adipose tissue sequesters vitamin D; hence individuals with high fat mass have 
lower serum 25(OH)D concentrations (36). High fat mass impairs exercise performance in young 
adults (13); consequently, high body fat and low availability of vitamin D may be responsible for 
poor performance in individuals with insufficient serum 25(OH)D concentrations. We have 
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additional confidence in Study 1 findings because the relationships were observed at the start of 
training and again after 12-weeks of training; both before and after taking account of incomplete 
training days due to illness and injury (Table 1). In terms of practical significance, the magnitude 
of the association between serum 25(OH)D and endurance performance in Study 1 can be 
considered small (Cohen’s f2 effect sizes < 0.15). Nevertheless, in real-world-terms, 1.5-mile run 
time was ~half-a-second faster for every 1 nmol·L
-1 
increase in serum 25(OH)D in men and 
women; equating to an ~20 s improvement in 1.5-mile run time for a 40 nmol·L
-1
 increase in 
serum 25(OH)D. 
Given the low prevalence of vitamin D sufficiency during wintertime in Study 1 (only 9% of 
men and 36% of women were vitamin D sufficient; Fig. 2B), in Study 2 we explored the 
possibility that achieving vitamin D sufficiency from its wintertime nadir would enhance 
exercise performance. Study 2 involved a unique comparison of safe, simulated, casual skin 
sunlight exposure and oral vitamin D3 supplementation specifically designed to achieve vitamin 
D sufficiency. Contrary to our hypothesis, achieving and maintaining IOM and EFSA defined 
vitamin D sufficiency in 97% of participants who received vitamin D supplementation (Fig. 3) 
did not benefit endurance, strength or power exercise performance (Table 2). 
 
Vitamin D and exercise performance 
Previous research relying upon cross-sectional designs that did not control for important 
confounders (e.g. body composition) may have overestimated the influence of vitamin D on 
exercise performance (8, 12). Consistent with this notion, in Study 1 we show that endurance 
performance was best in those with proposed optimal serum 25(OH)D ≥ 75 nmol·L-1 (Fig. 2C) 
(1, 2, 35). Our randomized placebo-controlled trial in contrast showed no beneficial effect of 
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achieving vitamin D sufficiency on exercise performance. Furthermore, in ~60% of our 
participants, vitamin D supplementation achieved the proposed optimal serum 25(OH)D ≥ 75 
nmol·L
-1 
but this did not lead to improved exercise performance. These findings agree with other 
randomized, controlled trials suggesting that oral vitamin D supplementation does not directly 
benefit exercise performance (15, 17, 37). We add to this body of work by showing that exercise 
performance is not improved when vitamin D status is increased by oral vitamin D3 or UVB 
supplementation. Although supplementation restored vitamin D sufficiency, the relatively small 
increase in serum 1,25(OH)2D (Fig. 4) could conceivably account for the absence of a beneficial 
effect on exercise performance. Whether larger vitamin D doses, achieving greater than normal 
seasonal changes in serum 25(OH)D (e.g. > 100 nmol·L
-1
), would have beneficial effects on 
exercise performance remains unclear. Although this may appear to be the logical next step in 
supplementation studies, larger vitamin D doses may be ineffective because they will increase 
serum 24,25-dihydroxyvitamin D (24,25(OH)2D) concentrations, which may impair VDR–
1,25(OH)2D mediated adaptations beneficial for exercise performance (11, 38). Moreover, higher 
doses of simulated sunlight and oral vitamin D3 in excess of tolerable upper intakes (4,000 
IU∙day-1) risk skin damage and vitamin D toxicity, respectively (3, 21). 
 
We recognize that the positive association between vitamin D status and endurance performance 
in Study 1 may be at least partly explained by reverse causation: individuals with greater long-
term physical activity are more likely to have greater aerobic fitness, spend more time outdoors 
exposed to sunlight and, in-turn, have higher serum 25(OH)D. A limitation of Study 1 is that we 
did not account for long-term physical activity in our regression model. If serum 25(OH)D 
concentration in Study 1 was reflective of an individual’s long-term vitamin D status, it may be 
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that long-term vitamin D sufficiency is necessary for optimal endurance performance. Therefore, 
12-weeks of vitamin D supplementation in Study 2 may have been an inadequate duration to 
benefit exercise performance. In accordance with this notion, an extended period of vitamin D 
supplementation improved skeletal muscle remodelling in untrained, young men during a 
progressive resistance training programme (39). However, the reported benefits of longer-term 
vitamin D supplementation on skeletal muscle remodelling did not translate to improved 
muscular strength (39). A further limitation of both Study 1 and Study 2 was that exercise 
performance was assessed using relatively simple exercise tests in the field environment. 
Notwithstanding, the strength of these tests is that they are functionally relevant for athletic and 
military performance, involving multiple joints working in synergy, and have been shown to 
predict functional task success and injury risk (22). Participants’ performance on the tests was 
also typical of recruits who had passed military entry standards, and directly relevant to young, 
physically active adults. Further research is recommended to confirm our findings in elite 
athletes. A limitation of Study 2 is that we only tested men; it was reasoned that vitamin D 
supplementation would most likely benefit exercise performance in men because vitamin D 
insufficiency was more prevalent in men than women in Study 1. We also acknowledge that 
Study 2 findings for SSR are only relevant to those with Fitzpatrick sun-reactive skin type I–IV 
(white skin) and not sun-reactive skin type V or VI (brown or black skin): serum 25(OH)D 
response to SSR in sun-reactive skin type V has been shown to be ~half that achieved in those 
with sun-reactive skin type I–IV (40). Exposure to springtime ambient UVB in Study 2 caused 
serum 25(OH)D to increase in the placebo groups at week 12 (Fig. 3). However, we 
demonstrated exposure to ambient UVB was not different between groups, and no effect of 
vitamin D supplementation on exercise performance was seen when vitamin D sufficient placebo 
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group participants were removed from analyses.     
 
Perspectives 
The American College of Sports Medicine’s recent Nutrition and Athletic Performance position 
stand called for research to investigate vitamin D’s potentially important influence on exercise 
performance; facilitating the determination of optimal vitamin D thresholds and supplementation 
recommendations (1). Our finding that vitamin D supplementation, even that which achieves the 
proposed optimal serum 25(OH)D ≥ 75 nmol·L-1, has no beneficial effect on exercise 
performance is therefore timely and has important implications for future nutrition and athletic 
performance recommendations. Despite evidence indicating that vitamin D supplementation does 
not benefit exercise performance, avoiding low serum 25(OH)D is considered important for 
musculoskeletal health (3, 4, 29). Vitamin D insufficiency is widespread in athletes and non-
athletes (1, 2). Correcting vitamin D insufficiency may also optimize training availability in 
athletes and military personnel by increasing resistance to upper respiratory tract infections (41) 
and reducing risk of injury (30). Our vitamin D supplementation strategies were effective in 
eliminating vitamin D deficiency and achieving vitamin D sufficiency in almost all. Future 
studies could use these methods to investigate the potential benefits of vitamin D 
supplementation on immune health and bone health; and the possible benefits of longer-term 
vitamin D supplementation. 
Rather than restoring vitamin D sufficiency from its winter nadir, as in Study 2, studies should 
investigate the effect of preventing the decline in end of summer serum 25(OH)D by 
commencing vitamin D supplementation in late summer or early fall and continuing until spring 
(~6-months). We propose the 400 IU∙day-1 oral vitamin D3 dose from the maintenance phase of 
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Study 2 for the purpose of maintaining end of summer vitamin D sufficiency: this oral vitamin 
D3 supplementation approach corresponds with current IOM and EFSA recommendations (3, 4). 
Oral vitamin D3 supplementation is recommended for this purpose because unlike simulated 
sunlight, there is no time burden for an individual; no requirement for bulky irradiation cabinets; 
and oral vitamin D3 supplementation is effective regardless of sun-reactive skin type (40). 
Studies are also required to further our understanding of how genetic variation between 
individuals (e.g. in vitamin D binding protein) might affect health and exercise performance 
outcomes to vitamin D supplementation (11). These studies, particularly those completed in 
diverse ethnic samples, should also consider assessing the bioavailable (free) fraction of vitamin 
D: health outcomes such as bone mineral density reportedly relate more closely to bioavailable 
vitamin D than to total serum 25(OH)D (11). 
 
Conclusion 
Vitamin D status predicted endurance exercise performance, but not strength or power, in a 
prospective cohort study of 967 young, healthy men and women after controlling for body 
composition, smoking and season. In a randomized, placebo-controlled trial, safe simulated 
summer sunlight or oral vitamin D3 were effective in achieving clinically important vitamin D 
sufficiency in almost all. However, vitamin D supplementation did not improve exercise 
performance, suggesting that vitamin D does not directly affect exercise performance.  
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Figure legends 
FIGURE 1. Schematic of Study 2 procedures, to investigate the effect of vitamin D 
supplementation by solar simulated radiation (SSR), oral vitamin D3 (ORAL), or placebo (SSR-P 
or ORAL-P) on exercise performance (1.5-mile run, maximum dynamic lift strength and 
explosive power), using a 4-week restoration phase followed by an 8-week maintenance phase. 
Syringe icon represents blood sample; Running icon represents 1.5-mile run; Weightlifting icon 
represents maximum dynamic lift strength; Jumping icon represents explosive power; PSF, 
polysulphone badge; FFQ, food frequency questionnaire.  
 
FIGURE 2. Seasonal variation in serum 25(OH)D (panel A) and percentage of participants 
categorized as vitamin D sufficient (serum 25(OH)D ≥ 50 nmol·L-1; panel B); and 1.5-mile run 
time by serum 25(OH)D quartiles (panel C) in 967 healthy, young men (n = 621) and women (n 
= 346) residing in the UK. a, lower than summer (P < 0.05). b, lower than fall (P < 0.05). c, 
lower than spring (P < 0.05). §, faster than quartiles 1, 2 and 3 (P < 0.05). Panel A and C data 
are mean ± SD.  
 
FIGURE 3. Serum 25(OH)D and percentage of participants categorized as vitamin D sufficient 
(serum 25(OH)D ≥ 50 nmol·L-1) in response to 12-weeks of vitamin D supplementation by solar 
simulated radiation (SSR) and oral vitamin D3 (ORAL). Panels A & B show combined active 
interventions (SSR and ORAL) vs. combined placebo (SSR-P and ORAL-P), panels C & D show 
SSR vs. SSR-P, and panels E & F show ORAL vs. ORAL-P. ††† P < 0.001, greater than 
baseline. ‡‡‡ P < 0.001, greater than week 5. * P < 0.05 and *** P < 0.001, greater than placebo. 
Data are mean ± SD. 
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FIGURE 4. Serum 1,25(OH)2D in response to 12-weeks of vitamin D supplementation by solar 
simulated radiation and oral vitamin D3 (SSR and ORAL) vs. placebo (SSR-P and ORAL-P). † P 
< 0.05 and †† P < 0.01, greater than baseline. ‡‡ P < 0.01, greater than week 5. * P < 0.05, 
greater than placebo. Data are mean ± SD. 
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Table 1. Serum 25(OH)D predicts 1.5-mile run time after controlling for fat mass, smoking and 
season, plus incomplete training days at follow-up. 
 
R
2 
overall ∆R2 
Sig. F 
change 
Standardized beta Cohen’s f2 
Males      
Baseline
 
0.20 0.04 < 0.001 -0.24 0.04 
Follow-up 0.29 0.06 0.002 -0.32 0.09 
Follow-up 
(incomplete 
training 
days added) 
0.30 0.06 0.002 -0.33 0.09 
Females      
Baseline
 
0.34 0.06 < 0.001 -0.26 0.08 
Follow-up 0.37 0.04 0.007 -0.23 0.06 
Follow-up 
(incomplete 
training 
days added) 
0.39 0.03 0.013 -0.22  0.05 
 
Cohen’s f2 ≥0.02, ≥0.15 and ≥0.35 represent small, medium and large effect sizes, respectively 
(33). 
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Table 2. Influence of 12-weeks solar simulated radiation (SSR), placebo solar simulated 
radiation (SSR-P), oral vitamin D3 (ORAL) and oral placebo (ORAL-P) on exercise 
performance. 
  SSR SSR-P ORAL ORAL-P 
1.5-mile run time (s)
 
Baseline 616 ± 34 633 ± 47 636 ± 42 631 ± 61 
∆Baseline to 
week 5 ### 
-20 ± 24 -14 ± 35 -32 ± 37 -28 ± 40 
∆Baseline to 
week 12 ### 
-40 ± 25 -33 ± 38 -49 ± 42 -54 ± 42 
Maximum dynamic 
lift strength (kg)
 
Baseline 70 ± 13 71 ± 12 68 ± 12 76 ± 13 
∆Baseline to 
week 12 
-1 ± 9  -1 ± 7 +1 ± 8 -3 ± 7 
Explosive power (W) Baseline 3888 ± 704 3930 ± 609 3808 ± 663 3911 ± 633 
 ∆Baseline to 
week 12 # 
-96 ± 306 -33 ± 332 -43 ± 345 -62 ± 322 
Interaction P > 0.05, SSR and ORAL vs. SSR-P and ORAL-P. Main effect of time vs. baseline, # 
P < 0.05 and ### P < 0.001. Data are mean ± SD. 
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